<!DOCTYPE html>
<html>
  <head>
    <meta charset="UTF-8">
    <style>
    body {
      margin-left: 72pt;
      margin-right: 72pt;
      margin-top: 72pt;
      margin-bottom: 72pt;
      font-size: 10pt;
      text-indent: 0pt;
    }
    </style>
  </head>
  <body>
    <p>Targeted sequencing analysis performed on this patient’s sample is POSITIVE for the following pathogenic variant (23P-044MP0027):</p>
    
<p style="text-align: justify;"> </p>

<p><strong>SINGLE NUCLEOTIDE VARIANTS AND INDELS</strong><span style="text-align: right;"><strong> </strong></span><span style="background-color: rgb(254, 254, 254);text-align: right;"><strong> </strong></span><span style="text-align: right;"> </span><span style="background-color: rgb(254, 254, 254);text-align: right;"> </span><span style="background-color: rgb(254, 254, 254);text-align: right;"> </span><span style="background-color: rgb(254, 254, 254);text-align: right;"> </span><strong>Alteration</strong><span style="background-color: rgb(254, 254, 254);"><strong>HGVS Nomenclature</strong></span><span style="background-color: rgb(254, 254, 254);"><strong>Coordinates</strong></span><span style="background-color: rgb(254, 254, 254);"><strong>Allele Frequency</strong></span><span style="text-align: right;"> </span><span style="background-color: rgb(254, 254, 254);text-align: right;"> </span><span style="background-color: rgb(254, 254, 254);text-align: right;"> </span><span style="background-color: rgb(254, 254, 254);text-align: right;"> </span><em>BCOR </em><em>in-frame internal tandem duplication (ITD) within exon 15</em><span style="background-color: rgb(254, 254, 254);"><em>NM_017745:c.5034_5121dup</em></span><span style="background-color: rgb(254, 254, 254);"><em>chrX:39911408::</em></span></p>

<p style="background-color: rgb(254, 254, 254);"><em>chrX:39911495 </em></p>

<p style="background-color: rgb(254, 254, 254);"><em> ~35%</em></p>

<p><strong>METHYLATION CLASSIFIER RESULTS (23P-044MP0028)</strong></p>

<p> </p>

<p><strong>METHYLATION CLASSIFICATION</strong></p>

<p><strong> </strong><strong>Calibrated Score</strong>Methylation class CNS high grade neuroepithelial tumor with <em>BCOR</em><em> alteration</em><em>0.93</em> </p>

<p> </p>

<p><em><strong>Methylation Class Description</strong></em></p>

<p><em><strong> </strong></em></p>

<p><em><strong>The methylation class "CNS high grade neuroepithelial tumor with BCOR alteration" is mainly comprised of tumors with the histological diagnosis CNS embryonal tumor, NOS, anaplastic ependymoma, and glioblastoma, IDH wildtype. Tumors can be located supratentorially or in the posterior fossa.  Molecularly, most cases harbor an internal tandem duplication in the BCOR gene. Rare cases harbor BCOR mutations. Up to 20% of cases show a gain of chromosome 1q; otherwise no recurrent copy number changes are observed, and most cases show a flat profile in copy number analysis. </strong></em></p>

<p><em><strong>  </strong></em></p>

<p><em><strong>LARGE-SCALE DNA COPY NUMBER ALTERATIONS</strong></em></p>

<p><em><strong> </strong></em></p>

<p><em><strong>Chromosomal losses:  No large-scale chromosomal losses</strong></em></p>

<p><em><strong> </strong></em></p>

<p><em><strong>Chromosomal gains: No large-scale chromosomal gains</strong></em></p>

<p><em><strong> </strong></em></p>

<p><em><strong>These molecular findings further confirms the diagnosis. High-grade neuroepithelial tumor (HGNET) with BCOR alteration (HGNET-BCOR) is now termed CNS tumor with BCOR internal tandem duplication in the current WHO classification of CNS tumors (WHO CNS5).</strong></em></p>
  </body>
</html>
